On March 23, 2022, Brooklyn ImmunoTherapeutics, Inc. closed the transaction. The transaction included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.736 USD | -0.25% | -19.27% | -3.30% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 9.39M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.47% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ERNA Stock
- News Eterna Therapeutics Inc.
- Brooklyn ImmunoTherapeutics, Inc. announced that it has received $11.999999 million in funding